Recent Updates
Recently added Catalysts
PEN

Penumbra, Inc. Schedules First Quarter 2016 Earnings Release and Conference Call for May 9, 2016 at 4:30 PM Eastern Time Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter ended March 31,...

Key Takeaway: ALAMEDA, Calif. , April 25, 2016 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the first quarter ended March 31, 2016 , after market close on Monday, May 9, 2016 at 4:30 PM Eastern Time. A press re

Full Press Release Details

ALAMEDA, Calif. , April 25, 2016 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the first quarter ended March 31, 2016 , after market close on Monday, May 9, 2016 at 4:30 PM Eastern Time. A press release with first quarter 2016 financial results will be issued after market close that day.
Webcast & Conference Call Information The conference call can be accessed live over the phone by dialing (877) 201-0168 for domestic callers or (647) 788-4901 for international callers (conference id: 92077838), or the webcast can be accessed on the "Investors" section of the Company's website at www.penumbrainc.com . The webcast will be available on the Company's website for two weeks following the completion of the call.
About Penumbra Penumbra, Inc., headquartered in Alameda, California , is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. The company has a broad portfolio of products that address challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe , Canada and Australia , and through distributors in select international markets. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.
Investor Relations Penumbra, Inc. 510-995-2461 [email protected]
SOURCE Penumbra, Inc.

Related Links

21 %

Last updated: Apr 25, 2016